Portola stock


Portola Pharmaceuticals Inc (PTLA): Oppenheimer Lowers Price Target Amid Apprehension Circling AndexXa’s Approval Timeline

Oppenheimer’s Jay Olson still sees 106% return potential for PTLA shares after dialing back the price target.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts